Table 1. Baseline characteristics (N = 130).
Figure 1. Overall survival according to the patients’ performance status at the beginning of eribulin treatment. Survival is significantly shorter among patients with PS 2–3. Kaplan–Meier survival analysis and log rank cow regression analysis is performed.
Table 2. Adverse events.
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
